New Jersey sues Insys as opioid maker settles with Massachusetts

BOSTON, Oct 5 (Reuters) - New Jersey on Thursday accused Insys Therapeutics Inc of engaging a fraudulent scheme to boost sales of a fentanyl-based cancer pain drug, as Massachusetts announced a $500,000 settlement with the drugmaker to resolve similar allegations. (Reporting by Nate Raymond in Boston)